A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder

Martin, Joanna ORCID: https://orcid.org/0000-0002-8911-3479, Hosking, Grace, Wadon, Megan, Agha, Sharifah Shameem ORCID: https://orcid.org/0000-0001-9541-6786, Langley, Kate ORCID: https://orcid.org/0000-0002-2033-2657, Rees, Elliott ORCID: https://orcid.org/0000-0002-6168-9222, Owen, Michael ORCID: https://orcid.org/0000-0003-4798-0862, O'Donovan, Michael ORCID: https://orcid.org/0000-0001-7073-2379, Kirov, George ORCID: https://orcid.org/0000-0002-3427-3950 and Thapar, Anita ORCID: https://orcid.org/0000-0002-3689-737X 2020. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder. Translational Psychiatry 10 , 135. 10.1038/s41398-020-0821-y

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (368kB) | Preview

Abstract

Recent case–control genetic studies of attention deficit hyperactivity disorder (ADHD) have implicated common and rare genetic risk alleles, highlighting the polygenic and complex aetiology of this neurodevelopmental disorder. Studies of other neurodevelopmental disorders, such as autism spectrum disorder (ASD), Tourette disorder, developmental delay/intellectual disability and schizophrenia indicate that identification of specific risk alleles and additional insights into disorder biology can be gained by studying non-inherited de novo variation. In this study, we aimed to identify large de novo copy number variants (CNVs) in children with ADHD. Children with a confirmed diagnosis of ADHD and their parents were genotyped and included in this sample. We used PennCNV to call large (>200 kb) CNVs and identified those calls that were present in the proband and absent in both biological parents. In 305 parent–offspring trios, we detected 14 de novo CNVs in 13 probands, giving a mutation rate of 4.6% and a per individual rate of 4.3%. This rate is higher than published reports in controls and similar to those observed for ASD, schizophrenia and Tourette disorder. We also identified de novo mutations at four genomic loci (15q13.1–13.2 duplication, 16p13.11 duplication, 16p12.2 deletion and 22q11.21 duplication) that have previously been implicated in other neurodevelopmental disorders, two of which (16p13.11 and 22q11.21) have also been implicated in case–control ADHD studies. Our study complements ADHD case–control genomic analyses and demonstrates the need for larger parent–offspring trio genetic studies to gain further insights into the complex aetiology of ADHD.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Advanced Research Computing @ Cardiff (ARCCA) Medicine
Publisher:	Springer Nature
ISSN:	2158-3188
Funders:	Wellcome Trust
Date of First Compliant Deposit:	8 April 2020
Date of Acceptance:	3 April 2020
Last Modified:	25 Jul 2024 16:02
URI:	https://orca.cardiff.ac.uk/id/eprint/130892

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item